DrugPatentWatch Database Preview
PROMETHAZINE HYDROCHLORIDE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Promethazine Hydrochloride patents expire, and what generic alternatives are available?
The generic ingredient in PROMETHAZINE HYDROCHLORIDE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for PROMETHAZINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 45 |
| NDAs: | 87 |
| Suppliers / Packagers: | 68 |
| Bulk Api Vendors: | 69 |
| Clinical Trials: | 39 |
| Patent Applications: | 1,834 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROMETHAZINE HYDROCHLORIDE at DailyMed |
Pharmacology for PROMETHAZINE HYDROCHLORIDE
| Ingredient-type | Phenothiazines |
| Drug Class | Phenothiazine |
Synonyms for PROMETHAZINE HYDROCHLORIDE
| (+-)-10-(2-(Dimethylamino)propyl)phenothiazine monohydrochloride |
| (+/-)-Promethazine Hydrochloride |
| (2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine Hydrochloride |
| 10-(2-(Dimethylamino)propyl)phenothiazine monohydrochloride |
| 10-(2-Dimethylamino-1-propyl)phenothiazine hydrochloride |
| 10-(2-Dimethylaminopropyl)phenothiazine hydrochloride |
| 10-(3-dimethylaminoisoprop yl)phenothiazine hydrochloride |
| 10-(3-Dimethylaminoisopropyl)phenothiazine hydrochloride |
| 10-[2-(Dimethylamino)propyl]phenothiazine hydrochloride |
| 10H-Phenothiazine-10-ethanamine, N,N,.alpha.-trimethyl-, hydrochloride (1:1) |
| 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, hydrochloride (1:1) |
| 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, monohydrochloride |
| 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, monohydrochloride, (+-)- |
| 10H-Phenothiazine-10-ethanamine,N,.alpha.-trimethyl-, monohydrochloride |
| 16639-38-6 |
| 3277 R.P |
| 3277 R.P. |
| 58-33-3 |
| 88208-28-0 |
| A831833 |
| AB0013086 |
| AC-12482 |
| AC1L1LM3 |
| AK163688 |
| AKOS016339657 |
| Allerfen |
| AN-41751 |
| Anergan 25 |
| Anergan 50 |
| API0003942 |
| AX8055660 |
| BBC/878 |
| Bonnox |
| CAS-58-33-3 |
| CCG-207895 |
| CCRIS 5873 |
| CHEBI:8462 |
| CHEMBL1200750 |
| Closin |
| component of Mepergan |
| CPD000058379 |
| CS-3543 |
| CTK8G2592 |
| D00480 |
| DIMETHYL[1-(10H-PHENOTHIAZIN-10-YL)PROPAN-2-YL]AMINE HYDROCHLORIDE |
| Diprasine |
| Diprazin |
| Dorme |
| DSSTox_CID_1192 |
| DSSTox_GSID_21192 |
| DSSTox_RID_76002 |
| DTXSID3021192 |
| Duplamin |
| EINECS 200-375-2 |
| EU-0100899 |
| Eusedon Mono |
| F0138-3355 |
| Farganesse |
| Fellozine |
| Fenergan |
| Frinova |
| FT-0631258 |
| Ganphen |
| Goodnight |
| H509 |
| Hibechin |
| Histantil |
| HL 8700 |
| HMS1570B18 |
| HMS1920L16 |
| HY-B0781 |
| J10089 |
| Kinetosin |
| KS-0000129F |
| KS-1385 |
| LP00899 |
| LS-40 |
| MCULE-6615710182 |
| MFCD00012652 |
| MLS000069398 |
| MLS001074184 |
| MLS002548850 |
| MolPort-003-666-272 |
| Mymethazine Fortis |
| N-(2-dimethylaminoprop-1-yl)phenothiazine hydrochloride |
| N-(2-Dimethylaminopropyl-1)phenothiazine hydrochloride |
| N-(2'-Dimethylamino-2-methylethyl)phenothiazine hydrochloride |
| N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine hydrochloride |
| N-(2'-Dimethylamino-2'-methylaethyl)-phenothiazin hydrochlorid |
| N-(2'-dimethylamino-2'-methylethyl)phenothiazine hydrochlor ide |
| N-(2'-dimethylamino-2'-methylethyl)phenothiazine hydrochloride |
| N,N-dimethyl-1-(10-phenothiazinyl)-2-propanamine hydrochloride |
| N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride |
| N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine hydrochloride |
| N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride |
| N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine monohydrochloride |
| NC00471 |
| NCGC00089735-04 |
| NCGC00094215-01 |
| NCGC00094215-02 |
| NCGC00094215-03 |
| NCGC00094215-04 |
| NCGC00094215-05 |
| NCGC00256588-01 |
| NCGC00259813-01 |
| NCGC00261584-01 |
| NSC 231688 |
| NSC-231688 |
| NSC-757301 |
| NSC231688 |
| NSC757301 |
| Opera_ID_1745 |
| P 4651 |
| P2029 |
| Pharmakon1600-01500510 |
| Phenadoz |
| Phencen |
| Phenergan |
| Phenergan (TN) |
| Phenergan Fortis |
| Phenergan hydrochloride |
| PHENERGAN PLAIN |
| Phenothiazine, 10-(2-(dimethylamino)-propyl)-, hydrochloride |
| Phenothiazine, 10-(2-(dimethylamino)propyl)-, monohydrochloride |
| Phergan |
| Pipolfen |
| Pipolphen |
| PL042703 |
| Plletia |
| PMS Promethazine |
| prim ine |
| Primine |
| Promantine |
| Prome |
| Prometh Fortis |
| Prometh Plain |
| Promethazine (hydrochloride) |
| Promethazine chloride |
| Promethazine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Promethazine Hcl |
| Promethazine hydrochloride (JP17/USP) |
| PROMETHAZINE HYDROCHLORIDE (SEE ALSO PROMETHAZINE 60-87-7) |
| Promethazine hydrochloride [JAN] |
| Promethazine hydrochloride [USP:JAN] |
| Promethazine Hydrochloride 1.0 mg/ml in Dimethyl Sulfoxide (as free base) |
| Promethazine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Promethazine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP |
| Promethazine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Promethazine hydrochloride, VETRANAL(TM), analytical standard |
| Promethazine hydrochloride, vial of 25 mg, certified reference material |
| Promethazine hydrochlorine |
| Promethazine monohydrochloride |
| Promethazine Plain |
| Promethazine.HCl |
| PromethazineHydrochloride |
| Promethegan (TN) |
| Promethiazin |
| Promethiazin [German] |
| Promine |
| Proneurin |
| Romergan |
| RP 3389 |
| s4293 |
| SAM002264636 |
| SC-19551 |
| SCHEMBL41904 |
| SMR000058379 |
| Soporil |
| SPECTRUM1500510 |
| SR-01000002993 |
| SR-01000002993-2 |
| ST24048193 |
| ST51015100 |
| Tox21_202264 |
| Tox21_302878 |
| Tox21_500899 |
| TRA0003095 |
| V GAN |
| Vallgerine |
| W-105399 |
| WLN: T C666 BN ISJ B1Y1&N1&1 &GH |
| XXPDBLUZJRXNNZ-UHFFFAOYSA-N |
| Z1259273234 |
| ZIPAN-50 |
US Patents and Regulatory Information for PROMETHAZINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 080949-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Watson Labs | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 083712-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Kv Pharm | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SYRUP;ORAL | 085388-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| G And W Labs | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 040428-001 | Feb 5, 2002 | AB | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
